Indomethacin and Cardiac Bypass Surgery
This study has been completed.
Sponsor:
Queen's University
Information provided by:
Queen's University
ClinicalTrials.gov Identifier:
NCT01073670
First received: February 19, 2010
Last updated: February 22, 2010
Last verified: February 2010
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | February 19, 2010 | ||||
| Last Updated Date | February 22, 2010 | ||||
| Start Date ICMJE | August 2000 | ||||
| Primary Completion Date | April 2002 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
amount of blood lost via chest drains during and following cardiac bypass surgery [ Time Frame: during surgery and then until chest drains removed (< 24 hours) ] [ Designated as safety issue: Yes ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT01073670 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
|
||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Indomethacin and Cardiac Bypass Surgery | ||||
| Official Title ICMJE | Quantification of Postoperative Coagulation Following Administration of Indomethacin to Expedite Fast-tracking of Cardiac Surgical Patients | ||||
| Brief Summary | Following signed informed consent, patients scheduled for elective cardiac surgery were randomly assigned to one of 3 groups to be given acetaminophen, Indomethacin or a combination of both immediately following induction and then at 6, 12, 18 & 24 hours following surgery. Our primary outcome measure was the amount of blood drained from the mediastinal tubes and chest drains. Secondary outcome measures included conventional blood coagulation indices as well as other measures of clotting as indicated by thromboelastography (TEG). Other secondary outcome measures included consumption of morphine equivalents and pain scores. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Phase 4 | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator) Primary Purpose: Supportive Care |
||||
| Condition ICMJE | Hemorrhage | ||||
| Intervention ICMJE |
|
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 82 | ||||
| Completion Date | April 2002 | ||||
| Primary Completion Date | April 2002 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | Not Provided | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Canada | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01073670 | ||||
| Other Study ID Numbers ICMJE | ANAE-062-00 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Dr. Joel Parlow, Head, Department of Anesthesiology & Perioperative Medicine, Queen's University and Kingston General Hospital | ||||
| Study Sponsor ICMJE | Queen's University | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Queen's University | ||||
| Verification Date | February 2010 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||